Atomwise


atomwise logo

Approach

Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve.

CEO:

Abraham Heifets

Founders:

Dr. Izhar Wallach

Abraham Heifets

First investment:

February 2018